About Gish Biomedical
Gish Biomedical is a Healthcare company based in Santa Margarita (United States) founded in 1976, and was acquired by Sorin Group in June 2010. Its focus areas include Traditional Medical Devices.
Company details
Manufacturer of traditional Italian gianduia chocolates and confectionery. The company produces a variety of products including gianduiotti, cremini, nocciolato, torrone, and coated chocolates. They also offer a selection of gift sets and impulse buys. The companys focus is on high-quality ingredients and traditional recipes, resulting in a range of classic Italian sweets. Production methods emphasize maintaining the authenticity and taste associated with their heritage.
- Headquarters Santa Margarita, United States
- Stage Acquired
- SectorsHealthcare
- Website gishbiomedical.com
- Social LinkedIn
- Acquired by Sorin Group (Jun 2010)
- InvestorsSorin Group
& 2 more
- Acquired by
Investors in Gish Biomedical
Gish Biomedical has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Sorin Group, Medos AG and VM Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VM Capital is engaged in managing family wealth through investments. | vmcap.com | Düsseldorf, Germany | ||
Medical devices for cardiac surgery and rhythm management are developed. | 1956 | sorin.com | Milan, Italy | |
Range of product and therapy solutions for cardiac surgeons and perfusionists. | 1978 | medos-ag.com | Stolberg, Germany |
Investor details for Gish Biomedical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Gish Biomedical
3 dated milestones of Gish Biomedical across 34 years, from founding to its latest funding, stage changes and deals.
- Founded Gish Biomedical is founded.
- Exit Acquired by VM Capital.
- Exit Acquired by Sorin Group.
Top companies in Traditional Diagnostics & Medical Devices
3 companies that operate in the same segment as Gish Biomedical (Traditional Diagnostics & Medical Devices) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Materials management solutions are provided for healthcare organizations. | 1892 | Chicago, Illinois, United States | USD 29.13 M | USD 20.63 B | 53,000 | |
3D-printed orthopedic products are manufactured for medical applications. | 1941 | Kalamazoo, Michigan, United States | ||||
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Gish Biomedical
Gish Biomedical was founded in 1976.
Gish Biomedical is headquartered in Santa Margarita, United States. It is registered at Santa Margarita, California, United States.
Manufacturer of traditional Italian gianduia chocolates and confectionery. The company produces a variety of products including gianduiotti, cremini, nocciolato, torrone, and coated chocolates. They also offer a selection of gift sets and impulse buys. The companys focus is on high-quality ingredients and traditional recipes, resulting in a range of classic Italian sweets. Production methods emphasize maintaining the authenticity and taste associated with their heritage.
Gish Biomedical has 3 investors. Key investors include Sorin Group, Medos AG, and VM Capital.
Yes. Gish Biomedical was acquired by Sorin Group in June 2010.